Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

9BDP

80S ribosome bound with angiogenin and complex of eEF1A and Ala-tRNAAla

This is a non-PDB format compatible entry.
Summary for 9BDP
Entry DOI10.2210/pdb9bdp/pdb
Related9BDL 9BDN
EMDB information44457 44458 44459 44460 44461 44463 44464
Descriptor18S rRNA, 60S ribosomal protein L7, Large ribosomal subunit protein eL8, ... (85 entities in total)
Functional Keywordsangiogenin, rnase, ribosome
Biological sourceHomo sapiens (human)
More
Total number of polymer chains86
Total formula weight3385481.16
Authors
Loveland, A.B.,Korostelev, A.A. (deposition date: 2024-04-12, release date: 2024-07-24)
Primary citationLoveland, A.B.,Koh, C.S.,Ganesan, R.,Jacobson, A.,Korostelev, A.A.
Structural mechanism of angiogenin activation by the ribosome.
Nature, 630:769-776, 2024
Cited by
PubMed Abstract: Angiogenin, an RNase-A-family protein, promotes angiogenesis and has been implicated in cancer, neurodegenerative diseases and epigenetic inheritance. After activation during cellular stress, angiogenin cleaves tRNAs at the anticodon loop, resulting in translation repression. However, the catalytic activity of isolated angiogenin is very low, and the mechanisms of the enzyme activation and tRNA specificity have remained a puzzle. Here we identify these mechanisms using biochemical assays and cryogenic electron microscopy (cryo-EM). Our study reveals that the cytosolic ribosome is the activator of angiogenin. A cryo-EM structure features angiogenin bound in the A site of the 80S ribosome. The C-terminal tail of angiogenin is rearranged by interactions with the ribosome to activate the RNase catalytic centre, making the enzyme several orders of magnitude more efficient in tRNA cleavage. Additional 80S-angiogenin structures capture how tRNA substrate is directed by the ribosome into angiogenin's active site, demonstrating that the ribosome acts as the specificity factor. Our findings therefore suggest that angiogenin is activated by ribosomes with a vacant A site, the abundance of which increases during cellular stress. These results may facilitate the development of therapeutics to treat cancer and neurodegenerative diseases.
PubMed: 38718836
DOI: 10.1038/s41586-024-07508-8
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.7 Å)
Structure validation

227111

PDB entries from 2024-11-06

PDB statisticsPDBj update infoContact PDBjnumon